BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 17349209)

  • 1. Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling.
    Carmody RJ; Chen YH
    Cell Mol Immunol; 2007 Feb; 4(1):31-41. PubMed ID: 17349209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling to NF-kappaB by Toll-like receptors.
    Kawai T; Akira S
    Trends Mol Med; 2007 Nov; 13(11):460-9. PubMed ID: 18029230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB.
    Gringhuis SI; den Dunnen J; Litjens M; van Het Hof B; van Kooyk Y; Geijtenbeek TB
    Immunity; 2007 May; 26(5):605-16. PubMed ID: 17462920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor and RIG-I-like receptor signaling.
    Kawai T; Akira S
    Ann N Y Acad Sci; 2008 Nov; 1143():1-20. PubMed ID: 19076341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acrolein with an alpha, beta-unsaturated carbonyl group inhibits LPS-induced homodimerization of toll-like receptor 4.
    Lee JS; Lee JY; Lee MY; Hwang DH; Youn HS
    Mol Cells; 2008 Apr; 25(2):253-7. PubMed ID: 18414004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights from vaccinia virus into Toll-like receptor signalling proteins and their regulation by ubiquitin: role of IRAK-2.
    Bowie AG
    Biochem Soc Trans; 2008 Jun; 36(Pt 3):449-52. PubMed ID: 18481979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells.
    Mäkelä SM; Strengell M; Pietilä TE; Osterlund P; Julkunen I
    J Leukoc Biol; 2009 Apr; 85(4):664-72. PubMed ID: 19164128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selenium suppresses the activation of transcription factor NF-kappa B and IRF3 induced by TLR3 or TLR4 agonists.
    Youn HS; Lim HJ; Choi YJ; Lee JY; Lee MY; Ryu JH
    Int Immunopharmacol; 2008 Mar; 8(3):495-501. PubMed ID: 18279804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity.
    Doyle SL; O'Neill LA
    Biochem Pharmacol; 2006 Oct; 72(9):1102-13. PubMed ID: 16930560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of TLR-4 and liver injury via NF-kappa B in rat with acute cholangitis.
    Yu H; Wu SD
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):185-91. PubMed ID: 18397856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin: tool and target for intracellular NF-kappaB inhibitors.
    Wullaert A; Heyninck K; Janssens S; Beyaert R
    Trends Immunol; 2006 Nov; 27(11):533-40. PubMed ID: 16982211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An RNA-binding protein alphaCP-1 is involved in the STAT3-mediated suppression of NF-kappaB transcriptional activity.
    Nishinakamura H; Minoda Y; Saeki K; Koga K; Takaesu G; Onodera M; Yoshimura A; Kobayashi T
    Int Immunol; 2007 May; 19(5):609-19. PubMed ID: 17383969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic dissection of antigen receptor induced-NF-kappaB activation.
    Li ZW; Rickert RC; Karin M
    Mol Immunol; 2004 Jul; 41(6-7):701-14. PubMed ID: 15220005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns.
    Mogensen TH; Paludan SR; Kilian M; Ostergaard L
    J Leukoc Biol; 2006 Aug; 80(2):267-77. PubMed ID: 16731773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation.
    Hu X; Chen J; Wang L; Ivashkiv LB
    J Leukoc Biol; 2007 Aug; 82(2):237-43. PubMed ID: 17502339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs targeting Toll-like receptors.
    Krishnan J; Lee G; Choi S
    Arch Pharm Res; 2009 Nov; 32(11):1485-502. PubMed ID: 20091261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway.
    Moynagh PN
    Trends Immunol; 2005 Sep; 26(9):469-76. PubMed ID: 16006187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin decreases TLR3-mediated inflammatory factor expression via inhibition of NF-kappa B activation in respiratory syncytial virus-infected RAW264.7 macrophages.
    Huang SH; Cao XJ; Wei W
    J Pineal Res; 2008 Aug; 45(1):93-100. PubMed ID: 18312297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the TLR/NF-kappaB pathway in antigen-presenting cells in malignancies promoted by inflammation.
    Blander JM
    Methods Mol Biol; 2009; 512():99-117. PubMed ID: 19347275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptors in innate immunity.
    Takeda K; Akira S
    Int Immunol; 2005 Jan; 17(1):1-14. PubMed ID: 15585605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.